Clinical Trial Update: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of combining levamisole with cyclosporine A in patients with paroxysmal nocturnal hemoglobinuria and coexisting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure
• Hemolytic Anemia
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Levamisole (levamisole)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria | Phase 2 | Status: UNKNOWN